Galvin, Gaustad & Stein »

Vertex Pharmaceuticals Incorporated shares owned by Galvin, Gaustad & Stein

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Galvin, Gaustad & Stein from 13F filings

Historical chart of Galvin, Gaustad & Stein investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Galvin, Gaustad & Stein consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Galvin, Gaustad & Stein

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 27k 418.01
2023-12-31 $8.6M 21k 406.89

More positions owned by Galvin, Gaustad & Stein

Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Bank of New York Mellon Corporation (BK)
Coca-Cola Company (KO)
Waste Management (WM)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Copart (CPRT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
AutoZone (AZO)
Visa Com Cl A (V)
Amazon (AMZN)

View all positions for Galvin, Gaustad & Stein

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated